| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Pasithea Therapeutics Corp. (KTTA) has 6 insiders with recent SEC Form 4 filings, including 1 buy and 0 sells. KTTA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 199.7K | $156.8K | - | |
| CEO | 73.3K | $57.6K | - | |
| Dir | 42.9K | $33.7K | - | |
| Dir | 35.8K | $28.1K | - | |
| Dir | 33.3K | $26.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2022 | Shahinian Eric | Member Of 10% Owner Group | Buy | 155,773 | $1.21 | $188,282.83 | +10.7% | -18.3% | -52.4% |